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Primary Sjögren’s syndrome (pSS) is a chronic 
inflammatory autoimmune disease that affects the sali-
vary and lacrimal glands, resulting in xerostomia and xe-
rophthalmia. Extraglandular manifestations in the joints, 
kidneys, respiratory tract, gastrointestinal tract and the 
vascular system may occur [1]. According to the latest 
recommendations issued by the American College of 
Rheumatology (ACR) in 2016, diagnosis of pSS requires 
a total score of ≥4 of the following 5 objective criteria, 
in patients with at least one symptom of ocular or oral 
dryness, or suspicion of pSS due to systemic features: 
(i) presence of focal lymphocytic sialadenitis with a fo-
cus score >1 focus/4 mm² in a labial salivary gland bi-
opsy (score: 3); (ii) anti-SSA and/or anti-SSB positivity 
(score: 3); (iii) an abnormal ocular staining score of ≥5 
or a van Bijsterveld score of ≥4 in at least one eye (score: 
1); (iv) a Schirmer’s test result of ≤5 mm/5 minutes in at 
least one eye (score: 1); (v) an unstimulated salivary flow 
rate of ≤0.1 ml/minute (score: 1) [2].
Measuring of the unstimulated salivary flow rate, 
which is useful for the assessment of salivary gland in-
volvement, is under critism because of its great variation 
over time in a single patient and its limited sensitivity 
and specificity [3]. On the other hand, a labial salivary 
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gland biopsy, which is the most important test in the as-
sessment of the salivary gland involvement, is invasive 
and, therefore, may cause complications. Furthermore, a 
lip biopsy can be misread by the pathologist. On a review 
of biopsies diagnosed as pSS, over half of the patients 
were reclassified [4]. There is a need for a reliable, non-
invasive method for the assessment of salivary gland in-
volvement. 
Ultrasonography (US) is among the imaging tech-
niques used to help diagnose pSS. The presence of paren-
chymal inhomogeneity (PIH) in pSS patients correlated 
well with the sialographic, scintigraphic and histological 
results. Nevertheless, a sonographically homogeneous 
parenchyma or mild PIH does not exclude pSS [5]. US 
elastography is a novel, non-invasive imaging method 
evaluating tissue stiffness. There are several types of 
elastographic examinations. Acoustic radiation force im-
pulse (ARFI) imaging is an elastography technique that 
provides an objective numerical evaluation of tissue stiff-
ness differently from the other elastography techniques 
[6]. It provides an estimate of tissue elasticity by meas-
uring the propagation of shear waves emitted during in-
duced tissue displacements [7]. The speed of the shear 
waves can be measured as shear wave velocity (SWV) 
and it is expressed quantitatively in meters per second 
(m/s). Stiffer tissues are associated with a higher SWV 
[8]. The benefits and usefulness of ARFI imaging have 
been shown in many clinical conditions, such as lesion 
detection and classification (e.g., in the breast, thyroid 
and prostate) and liver fibrosis staging [6,9-12]. There 
are also a few studies regarding the contribution and reli-
ability of ARFI imaging to the diagnosis of pSS [7,13-
15]. The aim of this prospective study is to investigate 
the diagnostic value of ARFI imaging in the assessment 
of salivary gland involvement in pSS.
Materials and methods
Study population
Twenty five patients diagnosed with pSS according 
to ACR 2016 and 25 healthy volunteers were included 
in this study. This study was approved by the medical 
ethics committee of the Baskent University Ankara Hos-
pital. Informed consent was obtained from all subjects, 
according to the World Medical Association Declaration 
of Helsinki, revised in 2000, Edinburgh. Exclusion cri-
teria included: the presence of any other associated au-
toimmune disease, past operations affecting the parotid 
or submandibular gland, past head and neck radiation 
treatment, history of sialolithiasis and history of using 
anticholinergic drugs. Healthy volunteers with preexist-
ing autoimmune disease, salivary gland-related disease 
or symptoms such as xerostomia, were exluded from the 
study. All patients’ clinical records, including their age, 
sex, antibody positivities, minor salivary gland biopsy 
results, Schirmer’s test results, and the date of onset of 
symptoms were noted.
Imaging technique
Ultrasonographic studies were performed using a 
9–14-MHz linear transducer (Acuson S3000, Siemens 
Healthcare, Erlangen, Germany) and adequate software 
for performing elastographic examinations in quantita-
tive ARFI mode (Virtual Touch Quantification®, VTQ). 
All patients were examined by the same operator. First, 
B-mode US was performed for all patients in order to 
assess glandular morphology. The echo structure of the 
parotid and submandibular glands in B-mode US was 
graded on a scale of 0 to 4 according to a previously pub-
lished scoring system [5]: stage 0 = normal homogene-
ity; stage 1 = mild parenchymal inhomogeneity (PIH) 
with hypoechoic areas <2 mm; stage 2 = evident PIH 
with hypoechoic areas of 2–6 mm; stage 3 = gross PIH 
with hypoechoic areas >6 mm; and stage 4 = adipose de-
generation of the gland, adipose tissue echogenicity, and 
parenchymal atrophy. Also, the thickness of the parotid 
and submandibular glands were measured in the longitu-
dinal plane. ARFI (VTQ) mode was then performed on 
the long-axis dimension of the parotid and submandibu-
lar glands. The transducer was gently applied together 
with a sufficient amount of contact gel. Every examina-
tion consisted of ten independent ARFI measurement 
(SWV) taken at a depth of approximately 1.0-1.5 cm in 
the center of the caudal pole of the parotid gland and the 
center of the submandibular gland, timed to the absence 
of swallowing maneuvers. The mean SWV value of the 
ten single SWV measurements was calculated for each 
gland, and used for further analysis.
Statistical analysis
All statistical analyses were performed using the Sta-
tistical Package for the Social Sciences (SPSS) software, 
Version 23.0 (SPSS, Chicago, IL, USA). Numerical vari-
ables, n → ∞ according to the Law of Large Numbers, 
the distribution of the sample mean approximates the 
normal distribution. Furthermore, since the numerical 
variables have a skewness (value / st.error) and a kurtosis 
(value / st.error) ratios of ± 2, the assumption is made 
that the normal distribution is appropriate. For numeri-
cal variables, mean, standard deviation, minimum and 
maximum values are given from the central tendency 
measures. Frequency distributions for categorical vari-
ables are given. An independent sample t test was used 
to examine the difference between the two independent 
groups. A dependent sample t test was used because the 
difference between submandibular glands and parotid 
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glands was examined and groups were dependent. In ad-
dition, pearson correlation coefficients were used in ex-
amining the relationship between the duration of symp-
toms and ARFI values. Cut-off values for submandibular 
and parotid glands were calculated, for use in the detec-
tion of salivary gland involvement in pSS.
Results
The mean age of the patients with pSS was 51.6 years 
(range 21-77 years), and in the healthy control group 47.3 
years (range 19-78 years). We detected a female predom-
inance in pSS patients (24 females, 96%). In the control 
group, there were 21 females (84%). Clinical features of 
the pSS patients were summarized in table I. In the patient 
group, the mean duration of symptoms was 44.5 months 
(range 2 months-10 years). In the evaluation of the US 
Fig 1. Box plots of mean right submandibular gland (a), left 
submandibular gland (b), right parotid gland (c), and left pa-
rotid gland (d) shear wave velocity (SWV) values in primary 
Sjögren’s syndrome patients (n=25) and in the control group 
(n=25). Solid line: median SWV values in m/s. 
Fig 2. Shear wave velocity (SWV) measurements in the left 
submandibular (a) and left parotid glands (b) of a 33-year-old 
healthy control volunteer. The SWV of the glands were meas-
ured with fixed measurement sample dimensions of 5x5 mm. In 
this patient, the mean SWV of the left submandibular and parot-
id gland were calculated as 1.50 m/s, and 1.76 m/s respectively. 
Fig 3. Shear wave velocity (SWV) measurements in the left 
submandibular (a) and left parotid glands (b) of a 58-year-old 
primary Sjögren’s syndrome patient, who was diagnosed 2 
years previous. The SWV of the glands were measured with 
fixed measurement sample dimensions of 5x5 mm. In this 
patient, the mean SWV of the left submandibular and parotid 
glands were calculated as 2.43 m/s, and 2.84 m/s respectively. 
The glands’ parenchyma are seen as homogeneous.
Table I. Clinical features of the primary Sjögren’s syndrome 
patients (n = 25)
Feature Frequency (%)
Xerostomia 22/25 (88)
Xerophthalmia 24/25 (96)
Positive Schirmer’s test 22/25 (88)
Positive biopsy results* 12/25* (48)
Autoantibodies positivity
ANA 
Anti-Ro 
Anti-La 
Rheumatoid factor
21/25 (84)
9/25 (36)
4/25 (16)
6/25 (24)
*Biopsy was not carried out in 8 (32%) patients.
patterns of the parotid and submandibular glands, the 
findings were concordant bilaterally in all cases. Stage 
0 (homogeneous gland parenchyma) was found in 17 
(68%) patients, stage 1 (mild inhomogeneity) in 6 (24%) 
and stage 3 (gross inhomogeneity) in 2 (8%) patients. In 
the control group, PIH was not observed. The values of 
mean thickness in the right submandibular, left subman-
dibular, right parotid, and left parotid glands were calcu-
lated as 11.8±2.3 mm, 11.3±1.6, 16.0±3.6, 15.1±2.3 in 
pSS patients, and 11.2±1.3, 11.6±1.2, 17.8±2.4, 17.6±2.0 
in the control group, respectively. There were no statisti-
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cally significant differences in the thickness of salivary 
glands between the two groups. 
The mean SWV values of parotid and submandibular 
glands were significantly higher in the pSS patients than 
in the healthy control group (p<0.001) (fig 1-4) (table II). 
The cut-off SWV values were calculated as 1.98 m/s for 
submandibular glands (sensitivity 0.84, specificity 0.92), 
and 1.93 m/s for parotid glands (sensitivity 0.92, speci-
ficity 0.92). As a result of the applied dependent sample 
t test, in pSS patients, the mean SWV values of parotid 
glands were found to be statistically significantly higher 
than the mean SWV values of submandibular glands 
(p<0.001).
In pSS patients, there was no statistically significant 
relationship between symptom duration or the degree of 
xerostomia and mean SWV values of parotid and sub-
mandibular glands (p>0.005).
Discussions
Our data indicate that ARFI imaging is a valuable tool 
in detecting salivary gland involvement in pSS. Recently, 
the effectiveness of ARFI imaging has been proven in 
detecting and assessing many conditions such as liver 
fibrosis or lesion characterization in many organs [6,9-
12]. With respect to salivary glands, there are studies that 
demonstrated higher SWV values by ARFI imaging in 
salivary glands previously exposed to radiotherapy, with 
inflammatory sialadenitis and with known sialolithi-
asis, than in normal glands [16,17]. There are also a few 
published sources regarding the contribution of ARFI 
imaging in pSS [7,13-15]. In their study, Hofauer et al 
[14] indicated that the most promising results among the 
sonoelastographic modalities in pSS, as an examiner-in-
dependent modality for the evaluation of salivary gland 
stiffness, was the ARFI imaging. Knopf et al [13] con-
cluded that ARFI imaging provided reliable, non-inva-
sive assessment of glandular impairment for identifying 
early pSS stages and in addition to histology, it was the 
most important diagnostic tool for identifying early pSS. 
Samier-Guarin et al [7] indicated that the ARFI imaging 
may contribute to the diagnosis of pSS, as a non-invasive 
investigation that can demostrate abnormal architectural 
changes in the parotid glands. Zhang et al [15] concluded 
that ARFI imaging (VTQ and also VTIQ) might be a 
valuable adjunct to the gray-scale US for the clinical di-
agnosis of pSS. In our study, we also found that, by ARFI 
imaging, SWV values of the parotid and submandibular 
glands were significantly higher in patients with pSS than 
in the healthy control group, even in the early stages of 
the disease. 
In our subjects, the mean SWV values of parotid 
glands were statistically significantly higher than the 
mean SWV values of submandibular glands in pSS pa-
tients. In the control group, there was relative symmetry 
of salivary gland elasticity and the difference was not 
statistically significant. Previously published studies are 
conflicting about this matter, which used different imag-
ing modalities. Izumi et al [18] obtained data confirming 
the histological results reported by Block et al [19], by 
using computed tomography and magnetic resonance im-
aging. They indicated that the major salivary glands also 
contained fatty infiltrates in patients with pSS and the fat 
signal seemed similar in the parotid and submandibular 
glands, although no numerical comparison between the 
two was reported. Zhang et al [15] reported that the stiff-
ness of parotid glands were not significantly different 
than those of the submandibular gland by ARFI imaging. 
However, the sialography results reported by Golder et 
al [20] are consistent with our results: they indicated that 
the lymphocytic infiltrate was more severe in the parotid 
Fig 4. Shear wave velocity (SWV) measurement in the left pa-
rotid gland of a 49-year-old primary Sjögren’s syndrome pa-
tient, who was diagnosed 7 years previous. In this patient, the 
mean SWV of the left parotid gland was calculated to be 2.91 
m/s. Gross parenchymal inhomogeneity with hypoechoic areas 
are seen in the gland parenchyma.
Table II. The mean shear wave velocity values of salivary glands in primary Sjögren’s syndrome patients and in the healthy control 
group
Salivary glands Mean SWV in pSS patients (m/s) Mean SWV in control group (m/s)
Right submandibular gland 2.20±0.28 1.80±0.14
Left submandibular gland 2.39±0.39 1.81±0.14
Right parotid gland 2.57±0.48 1.78±0.15
Left parotid gland 2.80±0.44 1.79±0.13
SWV – shear wave velocity; pSS – primary Sjögren’s syndrome
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glands than in the submandibular glands in patients with 
pSS. Also, in their studies, Samier Guarin et al [7], Knopf 
et al. [13], and Hofauer at al. [14] reported a discrepancy 
in SWV values between the parotid and submandibular 
glands, by ARFI imaging, similar to our results. This dis-
crepancy is most likely related to the different histologi-
cal composition of the parotid and submandibular glands 
[13]. While the serous parotid (and lacrimal) gland is pri-
marily affected by pSS, the mixed submandibular (and 
sublingual) gland is impaired to a lesser extent [21]. The 
exiguity of histological data on the parotid glands with 
pSS is probably attributable to the fact that parotid gland 
biopsies are not performed in this indication, given the 
risk of injury to blood vessels and nerves [13]. However, 
it may suggest that the histological changes, as lympho-
cytic sialadenitis, and the development of fibrosis might 
be more marked and/or occur earlier in the parotid glands 
than in the submandibular glands. It may also suggest 
that the evaluation of parotid glands may contribute to 
the diagnosis of pSS in the early stages of the disease, 
while the minor salivary gland biopsy is negative. 
Our analysis of side-to-side correlations for parotid 
and submandibular gland SWV values indicated a sym-
metrical distribution of the elasticity changes. However, 
Samier-Guerin et al [7] reported an asymmetrical distri-
bution in parotid and submandibular gland SWV values. 
Also, Golder et al [20] and Güne et al [22], reported in 
their studies that the inflammation of the major salivary 
glands in pSS is asymmetrical, at least in the early stages 
of the disease. Our findings suggest that a mean parotid 
gland SWV value greater than 1.93 m/s and a mean sub-
mandibular gland SWV value greater than 1.98 m/s may 
constitute an indirect indicator of structural changes in 
the salivary gland parenchyma. Nevertheless, the indi-
vidual values showed little overlap between the pSS pa-
tients and the control group. Probably, this condition is, 
again, due to the asymmetrical involvement of the gland 
parenchyma. Therefore, both sides of the salivary glands 
must be examined and the mean SWV value of ten in-
dependent measurements should be used for each gland. 
Several studies suggest that US may contribute to the 
diagnosis of pSS [23-25]. Patients with pSS may have 
an inhomogeneous salivary-gland structure due to the 
gradual development of hypoechoic foci. Nevertheless, a 
sonographically homogeneous parenchyma or mild het-
erogeneity does not exclude pSS [5]. In support of this 
condition, 68% of pSS patients’ glands parenchyma were 
homogeneous in our subjects. There are also studies about 
the role of real-time (strain) elastography in pSS patients 
[26,27]. In this technique, continuous transducer com-
pression or external mechanical compression is required 
to induce strain on tissues. Real-time elastography is eas-
ily influenced by several factors, such as operator depend-
ency, poor reproducibility and non-quantitative results 
[16] and may be ineffective in the diagnosis of the early 
stages of pSS [26]. ARFI imaging is an elastography tech-
nique, which requires no external compression, and SWV 
values provide a quantitative evaluation of tissue stiff-
ness. Knopf et al [13] reported that a reliable inter- and 
intra-rater reliability could be achieved with the imple-
mentation of a standard operating procedure. However, in 
their study Hofauer et al indicated that attention must be 
paid to ARFI imaging of the parotid gland, as inter-rater 
agreement between the experienced and inexperienced 
examiners was poor. Therefore, they recommended that 
only experienced examiners should performed ARFI im-
aging on parotid glands. Also they concluded that ARFI 
imaging in submandibular glands did not seem to be re-
producible for both experienced and inexperienced ex-
aminers. Pre-compression of the tissue, swallowing, or 
speaking by the patient can influence the SWV values in 
all organs [14,28,29]. Application of different amounts of 
pressure by the probe during the examination, can lead 
to the different results [14]. During the measurements of 
SWV it is necessary to pay attention to these points. In 
our study, all measurements were done by the same op-
erator with 5 years experience in ARFI imaging and great 
care was taken not to compress the glands. Currently, only 
the most sophisticated ultrasound machines are equipped 
with ARFI imaging software but ARFI imaging software 
will become increasingly available [7].
In our study, the age distribution of pSS patients and 
the control group was similar. Samier-Guerin et al al-
ready reported that there is no evidence that parotid or 
submandibular gland SWV values correlated with age in 
healthy controls aged 18 to 60 years [7].
The small sample size is the major limitation of our 
study. Also female dominancy may be considered as a 
limitation. Further evaluations are necessary, in a larger 
sample, in order to determine whether age is a potential 
confounding factor and to establish the accurate cut-off 
values.
In conclusion our findings indicate that ARFI imag-
ing is a non-invasive, simple and fast imaging technique 
for assessment the salivary gland parenchyma. The meth-
od can be used as an alternative test in the cases with in-
conclusive classical tests and may be a valuable adjunct 
for the clinical diagnosis of pSS. 
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